BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 29190611)

  • 1. Upregulated TRIM11 Exerts its Oncogenic Effects in Hepatocellular Carcinoma Through Inhibition of P53.
    Liu J; Rao J; Lou X; Zhai J; Ni Z; Wang X
    Cell Physiol Biochem; 2017; 44(1):255-266. PubMed ID: 29190611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM11 Upregulation Contributes to Proliferation, Invasion, and EMT of Hepatocellular Carcinoma Cells.
    Zhang Z; Xu C; Zhang X; Huang L; Zheng C; Chen H; Wang Y; Ju H; Yao Q
    Oncol Res; 2017 May; 25(5):691-699. PubMed ID: 28244856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Tripartite Motif-Containing Proteactiin 11 (TRIM11) is Associated with the Progression of Human Prostate Cancer and is Downregulated by MicroRNA-5193.
    Pan Y; Zhang R; Chen H; Chen W; Wu K; Lv J
    Med Sci Monit; 2019 Jan; 25():98-106. PubMed ID: 30608062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIM11 overexpression promotes proliferation, migration and invasion of lung cancer cells.
    Wang X; Shi W; Shi H; Lu S; Wang K; Sun C; He J; Jin W; Lv X; Zou H; Shu Y
    J Exp Clin Cancer Res; 2016 Jun; 35(1):100. PubMed ID: 27329103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription Factor MafB Promotes Hepatocellular Carcinoma Cell Proliferation through Up-Regulation of Cyclin D1.
    Yu H; Jiang HL; Xu D; Jin JZ; Zhao ZM; Ma YD; Liang J
    Cell Physiol Biochem; 2016; 39(2):700-8. PubMed ID: 27448450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
    Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
    J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ku80 functions as a tumor suppressor in hepatocellular carcinoma by inducing S-phase arrest through a p53-dependent pathway.
    Wei S; Xiong M; Zhan DQ; Liang BY; Wang YY; Gutmann DH; Huang ZY; Chen XP
    Carcinogenesis; 2012 Mar; 33(3):538-47. PubMed ID: 22226916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIM11, a new target of p53, facilitates the migration and invasion of nasopharyngeal carcinoma cells.
    Zhao Z; Deng J; Lu M; Yang J; Chen L; Li D; Sang Y
    Mol Biol Rep; 2023 Jan; 50(1):731-737. PubMed ID: 36376537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1-TSC2 complex.
    Guo P; Ma X; Zhao W; Huai W; Li T; Qiu Y; Zhang Y; Han L
    Oncogene; 2018 Jan; 37(4):478-488. PubMed ID: 28967907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tripartite motif-containing protein 11 promotes hepatocellular carcinogenesis through ubiquitin-proteasome-mediated degradation of pleckstrin homology domain leucine-rich repeats protein phosphatase 1.
    Yang J; Ye J; Ma T; Tang F; Huang L; Liu Z; Tian S; Cheng X; Zhang L; Guo Z; Tu F; He M; Xu X; Lu X; Wu Y; Zeng X; Zou J; Wang X; Peng W; Zhang P
    Hepatology; 2022 Sep; 76(3):612-629. PubMed ID: 34767673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of TRIM11 correlates with poor prognosis in patients with hepatocellular carcinoma.
    Chen Y; Li L; Qian X; Ge Y; Xu G
    Clin Res Hepatol Gastroenterol; 2017 Mar; 41(2):190-196. PubMed ID: 28065743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth.
    Di K; Linskey ME; Bota DA
    Oncogene; 2013 Oct; 32(42):5038-47. PubMed ID: 23178488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of TRIM26 inhibits the proliferation, migration and invasion of bladder cancer cells through the Akt/GSK3β/β-catenin pathway.
    Xie X; Li H; Pan J; Han X
    Chem Biol Interact; 2021 Mar; 337():109366. PubMed ID: 33549581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of Tripartite Motif Conaining 55 (TRIM55) Inhibits Migration and Invasion of Hepatocellular Carcinoma (HCC) Cells via Epithelial-Mesenchymal Transition and Matrix Metalloproteinase-2 (MMP2).
    Li X; Huang L; Gao W
    Med Sci Monit; 2019 Jan; 25():771-777. PubMed ID: 30685767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentivirus-mediated shRNA Targeting CNN2 Inhibits Hepatocarcinoma
    Kang X; Wang F; Lan X; Li X; Zheng S; Lv Z; Zhuang Y; Zhao Y; Zhou S
    Int J Med Sci; 2018; 15(1):69-76. PubMed ID: 29333089
    [No Abstract]   [Full Text] [Related]  

  • 16. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway.
    Zhu H; Wang J; Yin J; Lu B; Yang Q; Wan Y; Jia C
    Cell Physiol Biochem; 2018; 45(3):1121-1135. PubMed ID: 29439259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitidine chloride induces apoptosis in human hepatocellular carcinoma cells through a pathway involving p53, p21, Bax and Bcl-2.
    Ou X; Lu Y; Liao L; Li D; Liu L; Liu H; Xu H
    Oncol Rep; 2015 Mar; 33(3):1264-74. PubMed ID: 25530218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM65 triggers β-catenin signaling via ubiquitylation of Axin1 to promote hepatocellular carcinoma.
    Yang YF; Zhang MF; Tian QH; Zhang CZ
    J Cell Sci; 2017 Sep; 130(18):3108-3115. PubMed ID: 28754688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
    Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
    Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sorafenib inhibits proliferation and invasion of human hepatocellular carcinoma cells via up-regulation of p53 and suppressing FoxM1.
    Wei JC; Meng FD; Qu K; Wang ZX; Wu QF; Zhang LQ; Pang Q; Liu C
    Acta Pharmacol Sin; 2015 Feb; 36(2):241-51. PubMed ID: 25557114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.